BIOMARIN PHARMACEUTICAL INC | Business Contracts

Form of Agreement Regarding (Filed With SEC on February 27, 2023)

Form of Agreement Regarding Restricted Stock Units for the BioMarin Pharmaceutical Inc. 2017 Equity Incentive Plan (Filed With SEC on February 27, 2023)

Asset Purchase Agreement by and between Eli Lilly and Company, BioMarin Pharmaceutical Inc., and BioMarin International Ltd., dated February 8, 2022. Portions of this exhibit have... (Filed With SEC on April 29, 2022)

Form of Stock Options Agreement for the BioMarin Pharmaceutical Inc. 2017 Equity Incentive Plan (Filed With SEC on February 27, 2023)

Second Amendment to the Amended and Restated BioMarin Pharmaceutical Inc. Nonqualified Deferred Compensation Plan, as adopted October 4, 2022 (Filed With SEC on October 28, 2022)

BioMarin Pharmaceutical Inc. Summary of Independent Director Compensation (Filed With SEC on October 28, 2022)

Second amendment to the Amended and Restated BioMarin Pharmaceutical Inc. Nonqualified Deferred Compensation Plan, as adopted on October 5, 2021 (Filed With SEC on February 25, 2022)

First Amendment, dated May 28, 2021, to the Credit Agreement by and among BioMarin Pharmaceutical Inc., as the Borrower, Bank of America, N.A., as Administrative Agent, Swing Line... (Filed With SEC on July 30, 2021)

Part-Time Employment Agreement with Robert A. Baffi, Ph.D. effective January 1, 2021 (Filed With SEC on February 26, 2021)

Indenture, dated as of May 14, 2020, by and between BioMarin Pharmaceutical Inc. and U.S. Bank National Association, as Trustee, including the Form of Global Note, representing... (Filed With SEC on May 14, 2020)

Description of Capital Stock (Filed With SEC on February 27, 2020)

BioMarin Pharmaceutical Inc. Summary of Independent Director Compensation (Filed With SEC on October 29, 2019)

First Amendment to the Amended and Restated BioMarin Pharmaceutical Inc. Nonqualified Deferred Compensation Plan, as adopted June 4, 2019 (Filed With SEC on August 2, 2019)

BioMarin Pharmaceutical Inc. Amended and Restated 2006 Employee Stock Purchase Plan, as amended and restated April 12, 2019 (Filed With SEC on August 2, 2019)

BioMarin Pharmaceutical Inc. 2017 Equity Incentive Plan, as adopted April 10, 2017 and amended April 12, 2019 (Filed With SEC on August 2, 2019)

BIOMARIN PHARMACEUTICAL INC (15)